Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Multiple Antigen-Engineered DC Vaccine for Melanoma

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborator:
National Cancer Institute (NCI)
Information provided by (Responsible Party):
Lisa H. Butterfield, Ph.D., University of Pittsburgh
ClinicalTrials.gov Identifier:
NCT01622933
First received: June 14, 2012
Last updated: May 24, 2016
Last verified: May 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: October 2016
  Primary Completion Date: May 2016 (Final data collection date for primary outcome measure)